Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa
<p>Abstract</p> <p>Background</p> <p>GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative are working in partnership to develop a malaria vaccine to protect infants and children living in malaria endemic regions of sub-Saharan Africa, which can be deliver...
Автори: | , , , , , , , , , , , |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
BMC
2011-08-01
|
Серія: | Malaria Journal |
Онлайн доступ: | http://www.malariajournal.com/content/10/1/224 |